Genetic diversity and prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in aquatic environments receiving untreated hospital effluents

被引:7
作者
Kalasseril, Sneha Girijan [1 ]
Pillai, Devika [1 ]
机构
[1] Kerala Univ Fisheries & Ocean Studies, Dept Aquat Anim Hlth Management, Kochi, Kerala, India
关键词
antibiotic resistance; extended-spectrum beta-lactamase; hospital effluent; Kerala; public health; ANTIBIOTIC-RESISTANCE GENES; CLINICAL ISOLATE; WATER; SEWAGE; MUNICIPAL; HUMANS; EMERGENCE; COMMUNITY; BACTERIA;
D O I
10.2166/wh.2022.194
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The spread of extended-spectrum beta-lactamase (ESBL)-producing bacteria in the environment has been recognized as a challenge to public health. The aim of the present study was to assess the occurrence of ESBL-producing Escherichia coli and Klebsiella pneumoniae from selected water bodies receiving hospital effluents in Kerala, India. Nearly 69.8% of Enterobacteriaceae isolates were multi-drug resistant by the Kirby-Bauer disc diffusion method. The double disc synergy test was used to detect the ESBL production and the genes responsible for imparting resistance were detected by PCR. Conjugation experiments confirmed the mechanism of plasmid-mediated transfer of resistance. The prevalence of ESBL production in E. coli and K. pneumoniae was 49.2 and 46.8%, respectively. Among the ESBL-encoding genes, blaCTX-M was the most prevalent group followed by bla(TEM), bla(OXA), bla(CMY), and bla(SHV). The results suggest that healthcare settings are one of the key contributors to the spread of ESBL-producing bacteria, not only through cross-transmission and ingestion of antibiotics but also through the discharge of waste without a proper treatment, leading to harmful effects on the aquatic environment. The high prevalence of ESBL-producing Enterobacteriaceae with resistance genes in public water bodies even post-treatment poses a serious threat.
引用
收藏
页码:66 / 80
页数:15
相关论文
共 60 条
[1]   Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC β-lactamase, CMY-37 [J].
Ahmed, Ashraf M. ;
Shimamoto, Tadashi .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (03) :256-261
[2]   Call of the wild: antibiotic resistance genes in natural environments [J].
Allen, Heather K. ;
Donato, Justin ;
Wang, Helena Huimi ;
Cloud-Hansen, Karen A. ;
Davies, Julian ;
Handelsman, Jo .
NATURE REVIEWS MICROBIOLOGY, 2010, 8 (04) :251-259
[3]   blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003 [J].
Batchelor, M ;
Hopkins, K ;
Threlfall, EJ ;
Clifton-Hadley, FA ;
Stallwood, AD ;
Davies, RH ;
Liebana, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1319-1322
[4]  
BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[5]  
Bonafede, 2000, ANTIMICROB AGENTS CH, V44
[6]   β-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals [J].
Briñas, L ;
Zarazaga, M ;
Sáenz, Y ;
Ruiz-Larrea, F ;
Torres, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3156-3163
[7]   Updated Functional Classification of β-Lactamases [J].
Bush, Karen ;
Jacoby, George A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) :969-976
[8]   Past and Present Perspectives on β-Lactamases [J].
Bush, Karen .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
[9]   β-Lactams and β-Lactamase Inhibitors: An Overview [J].
Bush, Karen ;
Bradford, Patricia A. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (08)
[10]   CTX-M enzymes: origin and diffusion [J].
Canton, Rafael ;
Maria Gonzlez-Alba, Jose ;
Carlos Galan, Juan .
FRONTIERS IN MICROBIOLOGY, 2012, 3